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Neurodegenerative diseases have been linked to
inflammation, but whether altered immunomodula-
tion plays a causative role in neurodegeneration
is not clear. We show that lack of cytokine inter-
feron-b (IFN-b) signaling causes spontaneous neu-
rodegeneration in the absence of neurodegenerative
disease-causing mutant proteins. Mice lacking Ifnb
function exhibited motor and cognitive learning im-
pairments with accompanying a-synuclein-contain-
ing Lewy bodies in the brain, as well as a reduction
in dopaminergic neurons and defective dopamine
signaling in the nigrostriatal region. Lack of IFN-b
signaling caused defects in neuronal autophagy
prior to a-synucleinopathy, which was associated
with accumulation of senescent mitochondria. Re-
combinant IFN-b promoted neurite growth and
branching, autophagy flux, and a-synuclein degra-
dation in neurons. In addition, lentiviral IFN-b over-
expression prevented dopaminergic neuron loss in
a familial Parkinson’s disease model. These results
indicate a protective role for IFN-b in neuronal ho-
meostasis and validate Ifnb mutant mice as a model
for sporadic Lewy body and Parkinson’s disease
dementia.
INTRODUCTION
Neurodegenerative diseases have disrupted neuronal homeo-
stasis and their pathologies often overlap. Protein aggregates
containing a-synuclein (a-syn), which eventually forms larger
Lewy bodies (LBs), are seen in Parkinson’s disease (PD), demen-
tia with Lewy bodies (DLB), multiple system atrophy, and in some
forms of Alzheimer’s disease (AD), all neurodegenerative dis-
eases associated with aging (Arima et al., 1999; Francis, 2009;324 Cell 163, 324–339, October 8, 2015 ª2015 The AuthorsLippa et al., 1998). Often, the protein aggregates contain hyper-
phosphorylated tau and ubiquitin (Jellinger and Attems, 2008).
Neurodegenerative events in these diseases are linked to
inflammation (Mrak and Griffin, 2007; Tansey et al., 2008), but,
despite this link, defects in genes regulating inflammation do
not have an established causative role in neurodegeneration.
We report that deletion of Ifnb, which encodes interferon-b
(IFN-b), is sufficient to cause a cascade of neurodegenerative
events. IFN-b belongs to the type I interferon family of cytokines
and binding to its receptor, interferon-a/b receptor (IFNAR), re-
sults in immunoregulation including anti-viral and anti-inflamma-
tory effects (Prinz et al., 2008; Teige et al., 2003, 2006) and
benefits for multiple sclerosis patients (Liu et al., 2014; Yong
et al., 1998). However, the role of IFN-b in classic neurodegener-
ative diseases is unknown.We report that Ifnb–/–mice developed
spontaneous pathologies mimicking major aspects of human
neurodegeneration such as PD and DLB. Ifnb–/– mice had age-
associated motor learning defects, neuromuscular deficiencies,
and cognitive impairment. Ifnb–/– pathology was associated with
LBs resulting from defective neuronal autophagy. Autophagy, a
pathway that degrades long-lived proteins, organelles, lipids,
and protein aggregates, is essential for neuronal homeostasis
(Harris and Rubinsztein, 2012), and deleting neural autophagy-
regulating genes leads to neurodegeneration (Hara et al., 2006;
Komatsu et al., 2006).
Our findings indicate a central role for IFN-b in neuronal ho-
meostasis as a regulator of autophagy-mediated protein
degradation and accentuates Ifnb–/– mice as a model for neuro-
degenerative diseases with a-synucleinopathy and dementia
such as PD and DLB.RESULTS
Ifnb–/– Mice Exhibit Behavioral and Cognitive
Impairments and Neurodegeneration
We examined the effect of Ifnb gene deletion onmotor coordina-
tion, learning, and grip strength. Ifnb–/– mice were significantly
impaired in motor coordination and learning from 3 months
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Figure 1. Ifnb–/– Mice Exhibit Spontaneous Behavioral and Cognitive Impairments and Neurodegeneration
(A) Motor coordination by RotaRod. Data are mean second(s) ± SEM, n = 8–13/group. *p < 0.05, **p < 0.01 for genotype effect per time point by unpaired
Student’s t test; #p < 0.05 for aging effect. VVVp < 0.001 and xxp < 0.01 for genotype and aging effect, respectively, over time, by two-way ANOVA.
(B) Wire suspension performance. Data are mean ± SEM, 9–13/group.
(C and D) (C) Cold and (D) heat tail-flick latency. Data are mean ± SEM, 9–11/group.
(B–D) Unpaired Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001.
(E) Morris water maze test. Data are mean ± SEM, 8–21 mice/group. ###p < 0.001 shows genotype effect; Vp < 0.05 shows age effect; *p < 0.05 comparing
genotypes by two-way ANOVA and (*) with Bonferroni post hoc test.
(F) Representative maze swimming pattern on probes 1 and 2.
(G) TUNEL staining of hippocampus from 1.5-month-old mice with methyl green nuclear counterstaining. MoDG, molecular dentate gyrus; GrDG, granular
dentate gyrus; alv, alveus. Scale bar, 200 mm.
(H) H&E brain staining showing loss of granular cell layer and Purkinje cells (arrows) in Ifnb–/– hippocampus (upper) and cerebellum (lower). Scale bar, 200 mm.
(legend continued on next page)
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compared to age-, sex-, and weight-matched wild-type (WT)
Ifnb+/+ littermates and in latency-to-fall time in a wire-suspension
test (Figures 1A and 1B).We saw no differences in 1.5-month-old
mice, suggesting that impaired motor coordination, balance,
and grip strength were associated with age. During repeated
motor-learning trials, retention time improved significantly in
older Ifnb+/+ mice compared to Ifnb–/– mice from age 3 months
(Figure S1A), showing that reduced motor-learning in Ifnb–/–
mice was associated with aging.
We assessed somatosensory function with nociception cold-
and heat-induced tail-flick tests. Latency to tail flick was signifi-
cantly shorter in Ifnb–/– than Ifnb+/+ mice (Figures 1C and 1D),
indicating hyperalgesia and defective nociception toward tem-
perature-induced pain.
Forced swimming tests found no differences between Ifnb–/–
and Ifnb+/+ mice in swimming pattern, climbing effort, or immo-
bility (Figure S1), so Ifnb–/– mice were not defective in locomotor
activity in water in contrast to land. In water maze tests, Ifnb–/–
mice had significant spatial- and memory-learning deficits that
increased with age. During second tests, 6- and 12-month-old,
Ifnb–/– mice had significantly fewer platform position crossings
compared to Ifnb+/+mice, indicating impaired referencememory
(Figures 1E and 1F). Ifnb+/+ mice improved between the first and
second tests at all ages except 12 months; Ifnb–/– mice did not
improve, indicating impaired spatial learning. This was seen at
all ages in Ifnb–/– mice measured by escape latency time in the
second learning block (Figures S1B and S1C). Thus, although
Ifnb–/– mice began with no major behavioral and cognitive de-
fects, they developed age-dependent deficits with increased
penetrance (Table S1).
IFN-b Is Essential for Neuronal Survival, Neurite
Outgrowth, and Branching
We investigated whether Ifnb–/– behavioral deficits were associ-
ated with neurodegeneration. Apoptotic cells were detected in
1.5-month-old Ifnb–/– granular layers of olfactory bulbs (Fig-
ure S1E), the granular dentate gyrus of hippocampus and the
subventricular zone (Figure 1G), and the striatum (STR) caudate
putamen including the ependymal cell layer in 12-month-old
Ifnb–/–mice (Figure S1F), but not detected in Ifnb+/+ sagittal brain
sections at similar ages. Apoptotic neurons increased in cultured
Ifnb–/– primary cerebellar granular neurons (CGNs) and was
reversed by recombinant (r)IFN-b (Figures S1G and S1H).
Neurons were significantly reduced in the hippocampal CA1 re-
gion in 3- to 6-month-old Ifnb–/– mice and decreased in Purkinje
cells of cerebellum. Glial cell counts were unchanged (Figures
1H and 1I).
Supporting in vivo deficits in neuronal circuits, Ifnb–/–mice had
reduced neurite network formation in the cerebellum, frontal cor-
tex, and hippocampus granular cell layer (Figure 1J). This was
confirmed in cultured Ifnb–/– primary cortical neurons (CNs)
that had reduced neurite length per cell, mean length, and(I) Number of neurons and glial cells in hippocampus of 3- to 6-month-old mice.
(J) IF of 3-month-old brain sections. Scale bars, 10 mm.
(K) Z stack projections of CNs cultured for 4 and 21 days with or without rIFN-b.
(L) Quantified neurite length from 4-day-old CNs.
Data are mean ± SEM, n = 3–4, counting 11–32 cells per experiment. *p < 0.05, *
326 Cell 163, 324–339, October 8, 2015 ª2015 The Authorsbranch length per cell after 4 days, with restoration by rIFN-b
(Figures 1K and 1L). A similar trendwas seen after 21 days of cul-
ture (Figure 1K). Cultured primary Ifnb–/– CGNs mimicked the
findings of CNs (Figures S1I and S1J). Thus, behavioral defects
in old Ifnb–/– mice were associated with neuron death and
reduced neurite circuits.
Ifnb–/– Neuron Gene Profiling Reveals
Neurodegenerative Paths
We identified neuron-specific signaling and disease pathways
caused by IFN-b deficiency with expression microarrays on
highly pure (>98%) primary CGNs from Ifnb–/– and Ifnb+/+
mice plus or minus rIFN-b. Ifnb–/– neurons had 323 upregulated
and 233 downregulated genes (Figures 2A, 2B, and S2A).
rIFN-b treatment had differential effects on Ifnb+/+ versus
Ifnb–/– CGNs with approximately equal numbers of downregu-
lated and upregulated genes, but with relatively few overlaps
(Figures 2C–2F). Multiple genes in the Ifnb–/– data set annotated
as neuronal degeneration and the top ten pathways included
cell death and neurological disorders. Genes in neurite forma-
tion and branching suggested compromised neurogenesis
pathways in Ifnb–/– neurons, supporting the in vitro and in vivo
phenotypes (Figures 2G and 2H). To investigate whether Ifnb
and signaling via IFNAR affected neurogenesis in vivo,
3-month-old Ifnb–/– and IFNAR knockout (KO) mice (Ifnar–/–)
and WT littermates were injected with bromodeoxyuridine
(BrdU). Lack of Ifnb or receptor was associated with reduced
neurogenesis in the hippocampus; dentate gyrus (Figure 2I),
supporting the microarray data. IFN-b might directly affect
prosurvival mechanisms as neurotrophin was among the top
hits in gene set enrichment analysis (GSEA) (Table S2) and
mRNA for the corticogenesis-regulating transcription factor
Tox (Artegiani et al., 2015) was reduced in Ifnb–/– neurons (Fig-
ure S2A). Increased apoptosis and reduced neurogenesis
might contribute to impaired cognition and reduced hippocam-
pal neuron numbers. GSEA of Ifnb+/+ and Ifnb–/– showed
enrichment of genes associated with Huntington’s disease
(HD), PD, AD, and prion diseases, and rIFN-b caused the
Ifnb–/– profile to resemble WT (Figure 2J), supporting that com-
mon pathways link neurodegenerative diseases (Shulman and
De Jager, 2009).
We compared the Ifnb–/– neuronal gene profile with PD
and HD mouse models (Fossale et al., 2011). Three sets of
differentially expressed genes were generated: differentially
expressed in our data (p < 0.001), in our data and the HD
model (p < 0.01), or our data and the PD model (p < 0.01)
(Figures S2A–S2C; Data S1). Clustered genes in Ifnb–/–
neurons and the HD model were both similarly and oppositely
regulated. In contrast, most clustered genes in Ifnb–/– neurons
and the PD model were regulated similarly, thus indicating a
higher gene signature resemblance with PD than HD (Figures
S2B and S2C).Data are mean ± SEM, n = 6 mice/group. *p < 0.05 using Student’s t test.
Scale bar, 50 mm.
*p < 0.01, ***p < 0.001 by one-way ANOVA. See also Figure S1 and Table S1.
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Lack of Ifnb Causes Defects in the Nigrostriatal
Dopaminergic Pathway
Based on the possible PD-related defect in Ifnb–/– neurons, we
investigated nigrostriatal region integrity. Tyrosine hydroxylase
(TH)+ fiber density and TH+ (dopamine-producing) neurons
were significantly reduced in the STR and substantia nigra (SN)
in Ifnb–/– mice versus WT (Figures 2K and 2L). NeuN+ and
NeuN+TH+ cells were reduced in the ventral midbrain, which
was correlated with reduced TH protein in basal ganglia (BG) in
Ifnb–/– mice while total cells were unaffected (Figures 2M–2O).
Among differentially expressed genes in Ifnb–/– neurons, 31
(p = 6.937e-4) were involved in regulating dopamine (DA)
signaling (Figure 2P), which is involved in coordinating move-
ments. DA signaling was also defective in the STR. No major dif-
ferences were found in levels of DA or its metabolite homovanillic
acid (HVA) (data not shown) in 3- to 6-month-old Ifnb–/–mice, but
the DA metabolite dihydroxyphenylacetic acid (DOPAC) was
significantly lower, thus significantly affecting DA/DOPAC and
DOPAC/HVA ratios (Figure 2Q). These findings support the
importance of IFN-b in regulating dopamine turnover and pro-
tecting dopaminergic neurons.
Lack of Neuronal IFN-b-IFNAR Signaling Causes Lewy
Bodies
Since Ifnb–/– mice defects overlapped with neurodegenerative
diseases, particularly PD, we examined Ifnb–/– brain pathology.
Gross anatomy was unchanged, but histological examination
showed that Ifnb–/– neuron degeneration was associated with
age-dependent a-synucleinopathy. Staining for a-syn was
normal in 1.5-month-old Ifnb–/– brains; by 3 months, a-syn was
found in LB-like structures in SN; however, a-syn staining inten-
sity was reduced in 12-month-old Ifnb–/– mice (Figures S3A and
S3B), likely reflecting degeneration of TH+ neuron (Figure 2L).
Alpha-syn and large pathogenic aggregates of phosphorylated
(pSer129) a-syn were found in TH+ DA neurons of SN (Figure 3A).
At 3 months, a-syn aggregates were widespread in the STR,
frontal cortex (Figure 3B), hippocampus, and cerebellum (Fig-
ures S3C and S3D). Alpha-syn+ aggregates and neurites were
found sporadically in thalamus, the brainstem, and subthalamic
regions of 3-month-old Ifnb–/–mice (Figures S3E–S3G). Neurons
with a-syn+ LB-like structures increased with age (6- andFigure 2. Gene Profiling of Ifnb–/– Neurons Shows Association with Ne
Mouse Affymetrix 430 2.0 arrays.
(A–F) Venn diagrams for gene expression analysis of Ifnb–/–, Ifnb+/+ CGNs with or w
and E) Upregulated. (B, D, and F) downregulated genes.
(G and H) Gene expression analyzed for (G) top ten general signaling pathways a
(I) Neurogenesis in hippocampus dentate gyrus showing IF of an Ifnb+/+ mouse an
counted for BrdU+DCX+ neurons.
(J) GSEA Heatmaps of core-enriched pathways; HD, PD, AD, and prion diseas
rIFN-b, n = 3.
(K and L) IHC TH staining of coronal (K) STR and (L) SN sections. Data are (K) m
n = 4 mice.
(M and N) Stitched IF images showing NeuN (green) and TH (red) (M) immunoreact
regions.
(O) WB of BG from 8-month-old mice (n = 4). Graph, mean integral optical densi
(P) Overview of the DA system. Red, upregulated; blue, downregulated genes fro
(Q) High-performance liquid chromatography (HPLC) analysis of DA, DOPAC, an
For (I), (K), (L), (N), and (Q), *p < 0.05, **p < 0.01, ***p < 0.001, by Student’s t test
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Whole-brain protein extracts from 1.5-month-old mice were
not different from WT, but 3-month-old mice had significantly
increased a-syn in insoluble fractions and no difference in solu-
ble fractions (Figures 3E–3I). No difference in mRNA for a-syn
was observed between Ifnb–/– and WT brains (Figure 3J); thus,
the a-syn accumulation was not due to increased transcription.
The insoluble a-syn fraction in the BG (including SN) was signif-
icantly higher in older mice, but the soluble fraction was still
unchanged. A significant increase in high-molecular-weight
dimeric, trimeric, and oligomeric a-syn were seen in Ifnb–/–
mice, but with a decrease in tetramers. While aggregated
a-syn oligomers are neurotoxic (Rockenstein et al., 2014),
a-syn tetramers are suggested to be the normal aggregation
resistant conformation of the protein (Bartels et al., 2011;
Wang et al., 2011), possibly explaining the tetramer abundance
in Ifnb+/+ mice. pSer129-a-syn, which is prone to form patho-
genic fibrillar aggregates, was increased in Ifnb–/– mice (Figures
3K–3M). Ifnar–/– brains showed a similar pattern to Ifnb–/–
regarding a-syn and pSer129-a-syn accumulation (Figure S3H).
Blocking with a-syn96–140 peptide confirmed specific immunore-
activity for a-syn in Ifnb–/– brains. To ensure that lack of Ifnb did
not generate crossreacting a-syn-independent aggregates, we
generated Scna–/–Ifnb–/– double-KO mice (DKO). Ifnb–/– but not
Scna–/– or DKO mice had a-syn+ aggregates or LBs (Figures
S3I–S3K).
Accumulated polyubiquitinated proteins are associated with
neurodegenerative disease (Davies et al., 1997; Hara et al.,
2006; Komatsu et al., 2006). While 1.5-month-old WT and
Ifnb–/– mice showed not differences, 3-month-old Ifnb–/– brains
had increased polyubiquitin (Figures 3N–3R), in hippocampus
and cerebellum (Figures S3L and S3M), SN and locus coeruleus
(Figures 3O and 3P) and vestibular nuclei of pons (not
shown). Ubiquitin accumulated with inclusion body abundance,
as seen in the locus coeruleus of 12-month-old Ifnb–/– mice
(Figure 3Q) and a-syn+ aggregates colocalizing with ubiquitin
and phosphorylated Tau (pTau) significantly increased (Figures
3S and 3T).
To exclude systemic immune response influences, we
analyzed Ifnar–/– and nesCre:Ifnarfl/fl mice. Consistent with
Ifnb–/– mice, a-syn+ LB-like structures were found in theurodegenerative Diseases
ithout rIFN-b, n = 3. Genes differentially regulated by 1.5-fold, *p < 0.05. (A, C,
nd (H) nervous system development and function pathways.
d quantifying all groups: n = 4 mice/group and six to 12 sagittal sections were
e pathways were the top four neurologic disease pathways without or with
ean optical density (OD) ± SEM and (L) TH+ cell bodies per SN area ± SEM,
ivity and (N) quantifications of n = 4mice/group in three to four ventral midbrain
ty (IOD) ± SEM of TH bands.
m comparative microarray analysis of Ifnb+/+ and Ifnb/ CGNs.
d HVA in STR of 3- to 6-month-old mice, n = 9–10/group.
. See also Figure S2 and Data S1.
RQ
P
K L MHE
F
N O
I
JG
S T
U
C DB
A
V W
(legend on next page)
Cell 163, 324–339, October 8, 2015 ª2015 The Authors 329
cerebellum, granular and molecular layers (Figure S3N), and
significantly in thalamus of Ifnar–/– and nesCre:Ifnarfl/fl mice (Fig-
ure 3U). The ultrastructure of Ifnb–/– and Ifnar–/– neurons in
paratenial and central medial thalamic nuclei contained a-syn-
immunoreactive perinuclear LB-like structures (Figures 3V and
3W), which were absent in Ifnb+/+ mice (data not shown), under-
scoring the importance of endogenous IFN-b–IFNAR signaling in
preventing neuronal proteinopathy.
Lack of IFN-b Affects Autophagy
We used GSEA to identify cellular pathways involved in Ifnb–/–
neuron pathology. In the top 20 deregulated pathways, three
were associated with autophagy, which were restored with
rIFN-b (Figure 4A; Table S2). The autophagy system uses
adaptor proteins SQSTM1/p62 (hereafter p62) and NBR1 to
bind ubiquitinated proteins and LC3B-II in the autophagosomal
isolation membrane. Upon autophagy, cytosolic LC3B-I is con-
verted to membrane bound LC3B-II and blocking autophagy
flux, e.g., with Rab7 defects (Gutierrez et al., 2004; Hyttinen
et al., 2013), causes accumulation of autophagy-targeted pro-
teins; p62, NBR1, LC3B-II, and organelles. Increased neurons
with accumulated p62 were seen in 3-month-old Ifnb–/– brains
compared toWT, predominantly in brainstem, without increased
p62 mRNA. LC3B-II increased in BG of 1.5-month-old Ifnb–/–,
correlating with increased p62, NBR1 and Rab7, supporting
defects in autophagy before a-syn, ubiquitin, pTau, and LB
aggregation. Autophagy was even more deregulated in 6- to
8-month Ifnb–/– brains (Figures 4B–4H). Defective autophagy
was also confirmed in Ifnar–/– mice (Figure S4).
Senescent or damaged mitochondria are degraded by mi-
tophagy. Large, cytoplasmic, electron-dense aggregates asso-
ciated with lipid droplets were exclusively found in Ifnb–/– and If-
nar–/– thalamic neurons, which correlated with significantly more
mitochondria than in WT (Figures 4I–4M). Cultured Ifnb–/– neu-
rons had significantly lower mitochondrial membrane potential
(MMP) than Ifnb+/+ neurons, indicating senescent or damagedFigure 3. Ifnb–/– Mice Develop LBs with a-syn, Ubiquitin, and pTau
(A) IF of a-syn in SN of 6-month-old Ifnb–/– mice. Scale bar, 10 mm; 2 mm in close
(B) IF of 3-month-old Ifnb–/– brains showing a-syn+ neuron in frontal cortex and p
(C) IHC of a-syn in thalamus. Scale bar, 20 mm.
(D) Number of a-syn-positive LBs in thalamus of 6- and 12-month-old mice. ***p <
test for all groups.
(E–G) (E) WB of a-syn and quantified IOD in (F) soluble and (G) insoluble BG frac
(H and I) (H) WB of a-syn and (I) quantified IOD in TX-100 soluble and insoluble f
(J) RT-PCR of a-syn in Ifnb–/– relative to Ifnb+/+ brains. Data are mean ± SEM, n
(K) WB of a-syn (TX-100 soluble and insoluble) from BG of 8-month-old mice an
(L and M) Quantified IOD of a-syn and pSer129-a-syn in (L) insoluble and (M) solu
species (long exposure). Graphs, mean ± SEM, n = 5.
(N) WB and quantified ubiquitin IOD in BG from 1.5-month-old mice. Data are m
(O) IHC of ubiquitin in SN at 3 months and quantified ubiquitin+ aggregates/mm2.
(P and Q) IHC of ubiquitin in locus coeruleus at (P) 3 months and (Q) 12 months.
(R) WB and quantified ubiquitin IOD in brain extracts from 3-month-old mice. Da
(S and T) IF and quantification of (S) ubiquitin+a-syn+ and (T) p-tau+a-syn+ aggre
double positives ± SEM.
(U) IHC of a-syn in mice thalami showing LB-like structures (arrows). Scale bar, 50
one-way ANOVA and Turkey’s post hoc correction test.
(V and W) Immuno-EM of thalamic neurons from Ifnb–/– and Ifnar–/– mice showin
immunogold labeling.
For (I), (L), (M), (O), (R), (S), and (T), *p < 0.05, **p < 0.01, ***p < 0.001 by Student
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itive and negative regulators (Figure 4N). Thus, IFN-b signaling
was important in regulating autophagy flux including neuronal
mitophagy.
Late-Stage Autophagy Block Causes a-syn
Accumulation
Ifnb–/– CNs and CGNs and Ifnar–/– CNs showed autophagy de-
fects resembling a late-stage autophagy block (Figures 5A, 5B,
S5A, and S5B). In Ifnb–/– CNs, LC3B-I and LC3B-II were
increased with p62, NBR1, and K-63-linked ubiquitin, while
K-48-linked ubiquitin only increased slightly (Figures 5A and
5B). Both Ifnb+/+ and Ifnar–/– produced detectable IFN-b, unlike
Ifnb–/– neurons (Figure S5C). To validate a block in autophagy
flux, fusion between autophagosomes and lysosomes was in-
hibited with NH4Cl. At 1 hr, LC3B-II levels saturated in both ge-
notypes, which correlated with a significant increase in p62 in
Ifnb+/+ CNs; however, Ifnb–/– CNs had nearly saturated p62
levels without treatment, and no significant increase was seen
with NH4Cl (Figures 5C and 5D). Autophagy flux was measured
in CNs with the mRFP-GFP-LC3B construct, which emits
mRFP and GFP signal in autophagosomes and only mRFP in
autolysosomes because of low pH in the latter. Ifnb–/– CNs had
increasedmCherry+GFP+ autophagosomes and very few autoly-
sosomes compared to WT again suggesting blocked autophagy
flux. Treating Ifnb+/+ CNs with NH4Cl caused a similar distribu-
tion as Ifnb–/– CNs. Rab7 significantly increased in Ifnb–/– CNs,
suggesting accumulation of mature autophagosomes. In sup-
port, fewer LC3B- and p62-positive autophagic vacuoles over-
lapped with LAMP1, a lysosomal marker, in Ifnb–/– neurons
indicating flux or fusion problems (Figures 5E–5H). GSEA sug-
gested dysregulation in lysosomal genes in Ifnb–/– neurons
(Table S2). However, numbers and dysfunction of lysosomes
measured as acidification, morphology, or cathepsin expression
and activity did not differ in Ifnb+/+ and Ifnb–/– CNs and brains
(Figures S5D–S5I).-up lower panel.
ositive aggregates in STR. Scale bars, 10 mm.
0.001 by Mann-Whitney U test for two groups, yyyp < 0.001 by Kruskal-Wallis
tions of 1.5-month-old mice. Data are mean ± SEM, n = 4.
ractions of 3-month-old brains. Data are mean ± SEM, n = 5.
= 3–5.
d long exposure of whole membranes of soluble fractions.
ble fractions of monomeric (short exposure) and high-molecular-weight a-syn
ean ± SEM, n = 3.
Scale bar, 200 mm; 20 mm in inserts. Graph, mean ± SEM, n = 5.
Scale bar, 200 mm.
ta are mean ± SEM, n = 3.
gates in thalami of 12-month-old mice. Scale bar, 10 mm; data are percentage
mm. Graph, a-syn+ LB-like structures in thalamus ± SEM, n = 5. ***p < 0.001 by
g LB-like structures positive for a-syn by (V) immuno-DAB reactivity and (W)
’s t test. See also Figure S3.
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Ifnb–/– CNs developed ubiquitin+ a-syn aggregates and
increased monomeric and high-molecular-weight a-syn after
21 days of culture (Figures 6A and 6B). Accumulation of a-syn
was not due to proteasomal defects; turnover of the proteasome
substrate p53 after cycloheximide treatment and proteasomal
catalytic activity were uncompromised in Ifnb–/– CNs and un-
changed by rIFN-b (Figure S6).
Blocking autophagy flux increased LC3B-II and a-syn, and
a-syn colocalized with LC3B+ and p62+ autophagosomes in
Ifnb–/– CNs (Figures 6C and 6D), underscoring the relevance for
autophagic clearance of a-syn. Aggregation-prone pSer129-a-
syn was seen in LC3B+ autophagosomes, that rarely overlapped
with LAMP1. Collectively, these results demonstrated that
lack of IFN-b reduced lysosomal fusion and caused a-syn
accumulation.
IFN-b Promotes Neuronal Autophagy and a-syn
Clearance
LC3B-II and p62 were higher in untreated Ifnb–/– CNs, and, while
overnight rIFN-b-treatment promoted LC3B-II conversion and
reduced p62 in Ifnb+/+ CNs, indicating increased autophagy
flux, rIFN-b reduced p62 but only slightly increased LC3B-II in
Ifnb–/– CNs. By promoting autophagy, rIFN-b reduced a-syn in
both Ifnb+/+ and Ifnb–/– CNs (Figures 7A–7D). Effects of rapamy-
cin, an mTOR-dependent autophagy activator, were similar to
rIFN-b, but the mTOR-independent inducer trehalose more effi-
ciently reduced a-syn in CNs from both genotypes, possibly
through increased a-syn secretion (Ejlerskov et al., 2013). To
ensure reconstitution of the genetic defect, we cultured Ifnb–/–
neurons with a low rIFN-b dose for 21 days, which increased
autophagy flux and a-syn clearance to the level in Ifnb+/+ neurons
(Figures 7E and 7F).
Ifnb Gene Therapy Prevents Dopaminergic Neuron Loss
in a Familial PD Model
We used lentiviruses to overexpress IFN-b to examine effects on
a familial PD model induced with human a-syn (hSCNA) in rat
SNs. Injection of hSCNA and control lentiviruses blocked auto-
phagy indicated by accumulated LC3B-II, p62, NBR1, Beclin1,
and hSCNA in BG 10 days after SN injection (Decressac et al.,
2013) (Figures 7G and 7H). Ifnb overexpression prevented
hSCNA and pSer129-a-syn accumulation and restored TH
loss. The mice showed improved left paw use compared to right
paw use; contralateral to injection side of hSCNA/Ifnb andFigure 4. Late-Stage Degradative Autophagosomes Accumulate in Ifn
(A) Heatmaps of GSEA core-enriched genes in autophagy-related pathways co
(100 U/ml), n = 3.
(B) IHC from pons area using p62 antibodies. Scale bar, 20 mm.
(C) Quantification of p62+ cells/15 mm2. Data are mean ± SEM, n = 5.
(D) Fold change in p62 mRNA in brain extracts of 3-month-old mice. Data are m
(E–H) WB of BG of (E) 1.5-month-old and (G) 6- to 8-month-old mice and (F) and
(I–L) TEMof 9-month-oldmice thalami. (I–J) Ifnb–/–mice showing perinuclear electr
membrane and associated with lipid droplets. rER, rough endoplasmic reticulum
chondria in thalamic neuron cell body. M, mitochondria.
(M) Graph, mean ± SEMmitochondria per cell body of 12–16 thalamic neurons; **
comparisons test.
(N) TMRE analysis of 21-day-old CNs with mean TMRE area per cell, n = 3. *Tre
For (B), (C), (F), (H), and (N), */#p < 0.05, **p < 0.01, ***/###p < 0.001 by unpaired
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which was associated with preservation of TH+ fibers in SN (Fig-
ures 7I and 7J). Ifnb gene therapy also significantly protected
TH+ dopaminergic neurons from hSCNA-induced SN damage
(Figure 7K). Thus, IFN-b prevented pathology in a familial model
of PD by inducing autophagy and a-syn clearance.
DISCUSSION
CNS immune activation and inflammation occur in neurodegen-
erative diseases (Brochard et al., 2009; Lee et al., 2009;Maccioni
et al., 2009; Tansey et al., 2008), but their role in initiation is un-
clear. We report that defects in IFN-b-IFNAR signaling, that is
central to immune regulation, trigger neurodegeneration in the
CNS of aging mice. IFN-b promotes neurite growth and protein
degradation by autophagy. Lack of IFN-b causes neural patho-
logical changes: accumulation of LB-like structures, neural
apoptosis, and neurogenesis defects. p62 accumulated in
Ifnb–/– brainstems and BG regions before pathological a-syn
aggregation. Aggregates and LB-like structures with a-syn
were seen in brainstem and BG including SN, cortex, thalamus,
and cerebellum as previously reported in PD and DLB patients
(Goedert et al., 2013; Mori et al., 2003).
IFN-b is expressed by neurons to prevent malignant growth
(Liu et al., 2013) and neuroinflammation (Liu et al., 2014) and is
produced by choroid plexus epithelial cells in aged mouse and
human brains without CNS disease (Baruch et al., 2014). In the
latter study, injection of an anti-IFNAR antibody in the cerebro-
spinal fluid, however, positively affected some aspects of cogni-
tion. This approach could have complications as injection of
full-length antibody might initiate complement-dependent cyto-
toxicity (Nelson, 2010) and inflammation (Congdon et al., 2013;
Linnartz et al., 2012) and cause rapid antibody clearance
compared to isotype controls (Sheehan et al., 2006). Genetic
generation of Ifnb or Ifnar knockout mice or specifically targeting
neuroectodermal cells in nesCre:Ifnarfl/fl mice circumvents such
issues. We found that neuronal IFN-b-IFNAR signaling is
required for neurons to withstand age-associated pathology.
The data also suggest that neuronal IFN-b production in the
CNS parenchyma might function differently than high produc-
tion by choroid plexus epithelial cells or potentially resident
microglia.
Familial but not sporadic neurodegenerative diseases are
associated with overexpressed or mutant proteins such asb–/– Neurons
mparing Ifnb+/+ and Ifnb–/– mouse CGNs, Ifnb–/– with or without 24 hr rIFN-b
ean ± SEM, n = 3.
(H) quantified IOD of bands. Data are mean ± SEM of four or five brains.
on-dense late-stage autophagic vacuoles (AV), most surrounded by single lipid
. (K) Ifnar–/– mouse with similar electron-dense aggregates. (L) TEM of mito-
*p < 0.001, ****p < 0.0001 by one-way ANOVA with post hoc Dunnett’s multiple
atment effect, and #genotype effect.
Student’s t test. See also Figure S4 and Table S2.
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Figure 5. Ifnb–/– Neurons Have a Defect in Autophagy Maturation
(A–H) Ifnb+/+ and Ifnb–/– primary CNs cultured for 21 days.
(A) WB from three independent experiments with antibodies as indicated.
(legend continued on next page)
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a-syn in PD (Thenganatt and Jankovic, 2014). Overexpression of
disease-associated proteins (Arima et al., 1999; Jellinger, 2000;
Lippa et al., 1998) was not required to accumulate LB-like
structures in Ifnb–/–, Ifnar–/–, or nesCre:Ifnarfl/fl neurons. Ifnb or
Ifnar deletion was the sole trigger for a-syn-containing inclusion
bodies resulting from defective autophagosome maturation.
Treatment with rIFN-b promoted autophagy flux and increased
a-syn clearance in Ifnb+/+ and Ifnb–/– neurons, supporting
IFN-b function in mutated proteins clearance, as suggested
with ataxin 7 (Chort et al., 2013). Shared pathology of Ifnb–/–
and nesCre:Ifnarfl/fl mice suggests that the pathogenesis is
likely driven by initial changes in neuroectodermal neurons
rather than systemic or local immune activation. In agreement,
neurons are crucial for regulation of CNS inflammation (Liu
et al., 2006).
Protein degradation defects are common in neurodegenera-
tive pathologies (Davies et al., 1997; Hara et al., 2006; Komatsu
et al., 2006).We found that endogenous neuronal IFN-b signaling
is central in regulating protein degradation by autophagy,
including clearing aged mitochondria. Accumulated aged and
defective mitochondria may release reactive oxygen species,
enhancing neuroinflammation and neuronal death (Chaturvedi
and Flint Beal, 2013). Cognitive and motoric impairments in PD
is associated with DA dysfunction (Narayanan et al., 2013).
Excess cytosolic DA is degraded by monoamine oxidase
(MAO) in the mitochondrial outer membrane and MAO defects
might cause oxidative stress (Segura-Aguilar et al., 2014).
Senescent and damaged mitochondria and reduced MAO
mRNA were found in Ifnb–/– mice and reduced DOPAC in
Ifnb–/– mice supported dysregulation of MAO and mitochondrial
genes potentially contributing to neurotoxicity and DA neuron
death.
Lack of endogenous IFN-b signaling was associated with
spontaneous neurodegeneration, impaired motor coordination
and cognition, and neuronal LB-like inclusions with aging as
seen in most PD and DLB patients (Jellinger, 2008). Gene
profiling supported essential IFN-b regulation of neuronal ho-
meostasis. Neurotrophin was a top hit in GSEA and increased
Tox mRNA, important for corticogenesis (Artegiani et al., 2015),
supported IFN-b effects on prosurvival mechanisms.
We showed that Ifnb gene therapy reversed pathology in a
familial PDmodel, by promoting autophagy and a-syn clearance,
which preserved DA neurons and associated neurologic deficit.
Our data strongly support an essential role for IFN-b signaling in
preventing neurodegenerative pathology and suggest Ifnb–/–
mice as amodel for nonfamilial, sporadic neurodegenerative dis-(B) Quantified IOD of WB bands normalized to vinculin. Data are mean ± SEM, n
(C) WB of CNs with or without NH4Cl (20 mM) for 1 or 4 hr.
(D) Quantified IOD of WB. Data are mean ± SEM of n = 3, */#p < 0.05, **/##p < 0.01
treatment.
(E) CNs expressing mRFP-GFP-LC3B with or without NH4Cl for 2 hr. Arrowheads
(autolysosomes). Scale bars, 10 mm; 2 mm in inserts.
(F) Graphs, mean number of autophagosomes and autolysosomes/cell and vesic
(G) WB of Rab7. Graph, IOD of WB. Data are mean ± SEM of n = 3.
(H) IF showing LC3B and p62 colocalized in autophagosomes (arrowheads) and
10 mm; 2 mm in inserts.
For (B), (F), and (G), *p < 0.05, *p < 0.01, ***p < 0.001 by unpaired Student’s t tes
334 Cell 163, 324–339, October 8, 2015 ª2015 The Authorseases, particularly PD and DLB, with potential for testing future
therapies.
EXPERIMENTAL PROCEDURES
For detailed procedures, see Supplemental Experimental Procedures.
Mice and Cell Culture
Ifnb–/– mice (Erlandsson et al., 1998) were backcrossed 20 generations to
B10.RIII or C57BL6. Ifnar–/– and nesCre:Ifnarfl/fl mice were in C57BL6 (Prinz
et al., 2008). WT were Ifnb+/–, Ifnb+/+ littermates, or Ifnar+/+ C57BL6 mice.
C57BL/6JOlaHsd mice (Harlan Laboratories) with a spontaneous deletion of
part of Snca (a-syn) were crossed with Ifnb–/– mice for Scna–/–Ifnb–/–. Mice
were housed in standard facilities. Sex- and weight-matched mice were
used in experiments performed in accordance with the ethical committees in
Denmark and approved by our institutional review boards. CGNs were from
6- or 7-day-old cerebella and cortical neuron (CN) cultures from the cortex
of 1-day-old mice.
Behavioral Measurements
Motor-coordination and -learning were evaluated with an accelerating
RotaRod (TSESystemsGmbH) automatically recording timebefore fall. Neuro-
muscular strength was tested by forelimb hanging time on a bar. Heat and cold
tail-pain sensitivity was measured by tail-flick latency time after exposure.
Spatial learning and reference memory were assessed with Morris water
maze (Vorhees and Williams, 2006) with slight modifications. Swimming pat-
terns were recorded with Ethovision 3.1 (Noldus Information Technology),
measuring the time to reach a hidden platform during learning trials and fre-
quency of platform position crossings during probe tests. Deficits prevalence
were calculated as behavioral test scores of Ifnb–/–mice that deviated from the
norm: mean value (SD/2) of the Ifnb+/+ group (Table S1).
In the cylinder tests, asymmetry in forelimb use during vertical exploration
was used as a validated measure of akinesia in hemiparkinsonian rodents.
Cloning
Mouse Ifnb pCR4IFNb was from transOMIC (accession no. BC119395). Ifnb
was transferred to pCSII-GW via pCR8TOPOGW (Invitrogen) with conven-
tional cloning techniques to generate pCSII-IFNb. PCSII (without insert) was
generated by lambda recombination with an empty pCR8GW vector. Plasmid
inserts were verified by sequencing.
Surgery with AAV6-hSCNA
AAV-GFP or AAV-human a-syn/hSNCA-WPRE (Vector Biolabs) together with
lentiviral vectors pCSII-IFNb and pCSII control (3 ml for each virus) were in-
jected unilaterally into 30 adult female Sprague Dawley rats (Taconic; 225–
250 g at surgery). Virus was infused at 0.2 ml/min as described (Decressac
et al., 2013).
Immunohistochemistry, Immunofluorescence, and Transmission
Electron Microscopy
For immunohistochemistry (IHC) and immunofluorescence (IF), either mice
were perfused and brains fixed in 4% paraformaldehyde (PFA) and paraffin= 3.
by one-way ANOVA. *Within and # between genotype differences after NH4Cl
, colocalized GFP and mRFP (autophagosomes); arrows, mRFP-only vesicles
le ratio ± SEM, n = 3.
LC3B, LAMP1, and p62 colocalizing in autolysosomes (arrows). Scale bars,
t. See also Figure S5.
AB C
D
Figure 6. Autophagy Block Causes a-syn Accumulation
(A) IF of Ifnb–/– CN with inclusion body (arrow). Scale bar, 20 mm; 2 mm in insert.
(B) WB and quantified IOD bands of monomeric and high-molecular-weight (Mw) a-syn. Data are mean ± SEM, n = 3. *p < 0.05 by unpaired Student’s
t test.
(C) WB of Ifnb+/+ CNs treated with 20 mM NH4Cl.
(D) IF of CNs from Ifnb–/– mice. Arrows, triple colocalizing vesicular structures; arrowheads, LC3B and phosphorylated (Ser129) a-syn-positive vesicular
structures. Scale bars, 10 mm; 2 mm in inserts. See also Figure S6.embedded or brains were dissected and snap-frozen before sectioning.
In vitro neuronal cultures were fixed in 4% PFA before staining. Tissues and
cells were stained as described (Liu et al., 2014).
For neurogenesis and BrdU staining, mice were injected intraperitoneally
(i.p.) once per day (75 mg/g body weight) for 5 consecutive days and sacrificed
2 hr after last injection. Brains were processed and immunostained for BrdU
and doublecortin (DCX).
MMP was measured by adding tetramethylrhodamine ethyl ester (TMRE)
and Hoechst (Life Technologies) to primary CNs.
IF images were taken with a Zeiss LSM510 confocal scanning microscope
and IN Cell Analyzer 2200 automated microscope. IHC images were taken
with a NanoZoomer 2.0-HT digital slide scanner or Olympus BX51 micro-scope. Images were quantified with ImageJ (Fiji version), IN Cell Investigator,
CellProfiler, Zeiss Zen, and Adobe Photoshop.
In situ apoptosis detection was with TUNEL kits (Calbiochem) with Hoechst
counterstaining or DAB substrate and methyl green counterstaining kits (R&D
Systems).
For transmission electron microscopy (TEM), 12-month-old mice were car-
diac perfused with 2% PFA and 0.2% glutaraldehyde and paratenial, and cen-
tral medial thalamic nuclei were dissected and processed for epon embedding
and ultrathin sectioning. Samples were incubated with primary a-syn anti-
bodies (Leica) and biotinylated (Vector Laboratories) or 1.4-nm gold-labeled
secondary antibodies (Nanoprobes) and embedded in epoxy resin. Ultra-thin
sections were analyzed in a Philips CM100 electron microscope.Cell 163, 324–339, October 8, 2015 ª2015 The Authors 335
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Transfection and Plasmids
CNs were transfected with mRFP-GFP-LC3 using Lipofectamine 2000 (Life
Technologies) according to the manufacturer’s description for live-cell
confocal imaging.
Stereological Analysis
The optical fractionator method was used to estimate neuron and glial
numbers in the hippocampus of 80-mm mouse brain sections stained with
H&E. Pointcounting techniques, based on the Cavalieri principle, were used
to estimate hippocampal volume on one side of the brain.
Real-Time PCR
Total RNA was isolated using a QIAGEN kit (QIAGEN), reverse transcribed into
cDNA, amplified, and quantified by SYBR Green (Bio-Rad) detection. Relative
mRNA expression was normalizedwith glyceraldehyde 3-phosphate dehydro-
genase (Gapdh) gene.
High-Performance Liquid Chromatography
Striatumwas dissected and homogenized. Filtered supernatant was examined
for DA, DOPAC, and HVA levels by reversed-phase HPLCy (Decressac et al.,
2013).
Western Blots
Samples were lysed in 1% Triton X-100 (Sigma) and insoluble brain pellets
were sonicated in UREA/SDS and processed as described (Ejlerskov et al.,
2013).
Affymetrix Microarrays
RNA was extracted with TRI (Sigma) and DNase I (Invitrogen) from 3-day-old
Ifnb+/+ and Ifnb–/– CGN cultures in triplicate with or without 24 hr rIFN-b
(100 U/ml). Affymetrix 430 2.0 microarray chip (SCIBLU, Affymetrix) data
were analyzed with Arraystar 3 (DNA STAR) and quantile-normalized and pro-
cessed by the RMA (Affymetrix) algorithm. We log2-transformed intensity
values, and normal-distributed data were tested in unpaired two-tailed
Student’s t tests, filtering for differential regulation confidence of 95%
(p < 0.05). Venn diagrams were created with oneChannelGUI (Bioconductor).
Quantile-normalized RMA-treated data selected using a 1.4-fold cutoff were
analyzed with Ingenuity Pathway Analysis software.
GSEA data heatmaps were generated by extracting lists of core enriched
genes from GSEA pathway analysis in R using Heatmap2 (Data S1).
Comparisons of Ifnb–/–CGN gene profiles and published PD and HDmodels
using Affymetrix data (GSE4758, GSE9038) were quantile-normalized together
and summarized in R using RMA algorithms from the Affy-package. Differential
expression was determined individually within each experiment for our data
and published PD and HD models by comparing control/WT samples with
transgenic samples using standard ANOVA.Figure 7. IFN-b Treatment Promotes Autophagy Flux and Reduces a-s
(A–F) Ifnb+/+ and Ifnb–/– primary CNs cultured for 21 days.
(A) WB of CN with or without rIFN-b (100 U/ml) for 22 hr.
(B) Quantified IOD of WB bands. Graphs, mean ± SEM, n = 3; */#p < 0.05; ##p
group.
(C) WB of LC3, a-syn (two exposures), and vinculin from untreated or rIFN-b (10
(D) Quantified IOD of WB bands with mean ± SEM, n = 4–5. *After treatment with
(E) WB of CNs with 30 U/ml rIFN-b (every 3–4 days) and 100 U/ml the last 24 hr.
(F) Quantified IOD. Data are mean ± SEM, n = 4–6.
(G and H) WB of rat BG 10 days post AAV- and lentiviral-control or AAV-hSNCA
against autophagymarkers, human a-syn, or human and rat a-syn, pSer129-a-syn
n = 3/group.
(I) Right and left forepaw use in rats before and 21 days after AAV injection of hSNC
respectively. Graph, mean ± SD, n = 3–5 rats/group. *p < 0.05 by Student’s t tes
(J) IF of rat brain; right and left hemisphere 21 days after virus injection. Scale ba
(K) IHC of rat 21 days after virus injection as in (I) with SN TH immunoreactivity. G
hSCNA/lentivirus control, or AAV hSCNA/lentivirus-Ifnb, n = 3–5 rats/group.
For (B), (D), (F), (H), and (K), */#p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOStatistical Analysis
Data were analyzed with unpaired and paired two-tailed Student’s t tests,
ANOVA, and Mann-Whitney U, and Kruskal-Wallis tests. p < 0.05 was signifi-
cant. Error bars are SEM.
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